pcDNA3-GFP-IMP2-2_antisense-control Citations (2)

Originally described in: IGF2 mRNA binding protein p62/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2/PI3K signaling.
Kessler SM, Pokorny J, Zimmer V, Laggai S, Lammert F, Bohle RM, Kiemer AK Am J Physiol Gastrointest Liver Physiol. 2013 Feb 15;304(4):G328-36. doi: 10.1152/ajpgi.00005.2012. Epub 2012 Dec 20. PubMed Journal

---

Articles Citing pcDNA3-GFP-IMP2-2_antisense-control

Articles
IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype. Kessler SM, Laggai S, Barghash A, Schultheiss CS, Lederer E, Artl M, Helms V, Haybaeck J, Kiemer AK. Cell Death Dis. 2015 Oct 1;6:e1894. doi: 10.1038/cddis.2015.241. PubMed
A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancer. Kendzia S, Franke S, Krohler T, Golob-Schwarzl N, Schweiger C, Toeglhofer AM, Skofler C, Uranitsch S, El-Heliebi A, Fuchs J, Punschart A, Stiegler P, Keil M, Hoffmann J, Henderson D, Lehrach H, Yaspo ML, Reinhard C, Schafer R, Keilholz U, Regenbrecht C, Schicho R, Fickert P, Lax SF, Erdmann F, Schulz MH, Kiemer AK, Haybaeck J, Kessler SM. Mol Cancer. 2023 May 30;22(1):89. doi: 10.1186/s12943-023-01787-x. PubMed

If you have published an article using this material, please email us at to have your article added to this page.